ArticleJournal of immunology research2024

Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.

Yan-Hua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.